Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Functional Genomics Takes Form

This article was originally published in Start Up

Executive Summary

By 1994, functional genomics companies began forming to help a Big Pharma suddenly deluged by genomic data. Through the study of model genetic systems like nematodes and fruit flies, or homogenous peoples, these gene hunters hope to gain an understanding of how and when genes function--under normal conditions and in disease.

You may also be interested in...

Oxagen Ltd.

Oxagen's goal is to use large familial clinical groups and sample banks to identify disease genes through agreements with three groups of academic clinical investigators, located throughout Europe.

polyGenomics Inc.

PolyGenomics was spun-out of Yale University to develop a genetic amplification technology in the search for genes implicated in psychiatric illnesses.

GenoPlex Inc.

GenoPlex Inc. hopes to provide validated gene targets to Big Pharma. The company is focusing its gene-seeking efforts on aging, learning and memory, and the action of anesthetics and alcohol.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts